Health
STAT+: The biotech startups skipping AI for drug discovery
In this edition of AI Prognosis: These biotech startups don't think drug discovery is where AI can make the biggest difference.
- Published
- (9 h ago)
- Outlet
- STAT News
- Section
- Health
- Length here
- Headline and 21-word snippet. The full article is at the source.
More from STAT News and around the same time
STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding billSanders could use his role in crafting the bill to push for reforms.STAT+: Mass. marijuana consumers, workers high on victory after repeal of recreational weed sales fails in a routMassachusetts voters decisively shot down a ballot initiative that would have dismantled the state’s recreational cannabis industry.STAT+: Democratic doctors and scientists ride the blue waveThe clinicians and researchers who will take office are ready to tackle the U.S. health care system.STAT+: Where does MAHA go from here? Three possible futuresRepublican losses leave Robert F. Kennedy Jr.’s MAHA movement with three possible futures.STAT+: CVS Health to split, reversing years of deal-making to combine pharmacies and insuranceCVS Health’s decision to split comes amid federal and state scrutiny over vertical integration.STAT+: A looming deadline to fund the government will shape Congress’ unusual lame duck sessionBefore Democrats take control, Congress must fund expiring health care programs, confirm HHS nomineesThis page holds the headline and a short snippet as published by STAT News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
